These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623 [TBL] [Abstract][Full Text] [Related]
51. Effects of recombinant plasminogen activator inhibitor type 1 on fibrinolysis in vitro and in vivo. Knabb RM; Chiu AT; Reilly TM Thromb Res; 1990 Jul; 59(2):309-17. PubMed ID: 2122539 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of tissue plasminogen activator in an isolated extracorporeal circuit. Geier B; Grossefeld M; Barbera L; Mumme A J Vasc Surg; 2001 Jan; 33(1):165-9. PubMed ID: 11137937 [TBL] [Abstract][Full Text] [Related]
53. No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteers. Kemme MJ; Burggraaf J; Schoemaker RC; Cohen AF Thromb Res; 2001 Jul; 103(1):9-16. PubMed ID: 11434941 [TBL] [Abstract][Full Text] [Related]
54. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain. Rydzewski A; Castellino FJ Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682 [TBL] [Abstract][Full Text] [Related]
56. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis. Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416 [TBL] [Abstract][Full Text] [Related]
57. Intravitreal clearance of tissue plasminogen activator in the rabbit. Jaffe GJ; Green GD; McKay BS; Hartz A; Williams GA Arch Ophthalmol; 1988 Jul; 106(7):969-72. PubMed ID: 3134000 [TBL] [Abstract][Full Text] [Related]
58. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Haley EC; Brott TG; Sheppard GL; Barsan W; Broderick J; Marler JR; Kongable GL; Spilker J; Massey S; Hansen CA Stroke; 1993 Jul; 24(7):1000-4. PubMed ID: 8322373 [TBL] [Abstract][Full Text] [Related]
59. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain. Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628 [TBL] [Abstract][Full Text] [Related]
60. Determination, pharmacokinetics and protein binding of a novel tissue-type plasminogen activator, pamiteplase in human plasma. Oikawa K; Watanabe T; Miyamoto I; Higuchi S Xenobiotica; 2000 Oct; 30(10):993-1003. PubMed ID: 11315107 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]